Dr. Vonderheide is an internationally renowned cancer immunotherapy and translational research expert. Through a focus on novel immunotherapies for pancreatic cancer, melanoma and breast cancers, Dr. Vonderheide has mapped new models for speeding translational - or "bench to bedside" research. He is currently the Director of the Abramson Cancer Center.
Servicesabdominal chemotherapy, biological targeted therapy, breast cancer immunotherapy, cancer chemotherapy, cancer immunotherapy, colon cancer chemotherapy